Summit Therapeutics Inc (SMMT)
19.00
+0.58
(+3.15%)
USD |
NASDAQ |
Nov 22, 16:00
19.02
+0.02
(+0.11%)
After-Hours: 20:00
Summit Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.22M |
| June 30, 2022 | 0.235M |
| March 31, 2022 | 0.25M |
| December 31, 2021 | 0.251M |
| September 30, 2021 | 1.309M |
| June 30, 2021 | 0.057M |
| March 31, 2021 | 0.192M |
| December 31, 2020 | 0.185M |
| September 30, 2020 | 0.181M |
| June 30, 2020 | 0.17M |
| March 31, 2020 | 0.324M |
| October 31, 2019 | 0.16M |
| Date | Value |
|---|---|
| July 31, 2019 | 0.1532M |
| April 30, 2019 | 0.322M |
| January 31, 2019 | 3.071M |
| October 31, 2018 | 0.8578M |
| July 31, 2018 | 49.86M |
| April 30, 2018 | 5.334M |
| January 31, 2018 | 5.457M |
| October 31, 2017 | 3.480M |
| July 31, 2017 | 6.243M |
| April 30, 2017 | 2.234M |
| January 31, 2017 | 2.176M |
| October 31, 2016 | 0.7034M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.057M
Minimum
Jun 2021
1.309M
Maximum
Sep 2021
0.3067M
Average
0.22M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Merck & Co Inc | 16.66B |
| Terns Pharmaceuticals Inc | -- |
| Instil Bio Inc | -- |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 1.855B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.25M |
| Total Expenses (Quarterly) | 58.38M |
| EPS Diluted (Quarterly) | -0.08 |
| Enterprise Value | 13.55B |
| Earnings Yield | -1.26% |
| Normalized Earnings Yield | -3.165 |